tetano
Editor, Senior Moderator
Infect Genet Evol
. 2020 Aug 31;104517.
doi: 10.1016/j.meegid.2020.104517. Online ahead of print.
Genome based evolutionary lineage of SARS-CoV-2 towards the development of novel chimeric vaccine
Mst Rubaiat Nazneen Akhand[SUP] 1 [/SUP], Kazi Faizul Azim[SUP] 2 [/SUP], Syeda Farjana Hoque[SUP] 3 [/SUP], Mahmuda Akther Moli[SUP] 3 [/SUP], Bijit Das Joy[SUP] 1 [/SUP], Hafsa Akter[SUP] 4 [/SUP], Ibrahim Khalil Afif[SUP] 5 [/SUP], Nadim Ahmed[SUP] 4 [/SUP], Mahmudul Hasan[SUP] 6 [/SUP]
Affiliations
Abstract
The present study aimed to predict a novel chimeric vaccine by simultaneously targeting four major structural proteins via the establishment of ancestral relationship among different strains of coronaviruses. Conserved regions from the homologous protein sets of spike glycoprotein, membrane protein, envelope protein and nucleocapsid protein were identified through multiple sequence alignment. The phylogeny analyses of whole genome stated that four proteins reflected the close ancestral relation of SARS-CoV-2 to SARS-COV-1 and bat coronavirus. Numerous immunogenic epitopes (both T cell and B cell) were generated from the common fragments which were further ranked on the basis of antigenicity, transmembrane topology, conservancy level, toxicity and allergenicity pattern and population coverage analysis. Top putative epitopes were combined with appropriate adjuvants and linkers to construct a novel multiepitope subunit vaccine against COVID-19. The designed constructs were characterized based on physicochemical properties, allergenicity, antigenicity and solubility which revealed the superiority of construct V3 in terms safety and efficacy. Essential molecular dynamics and Normal Mode analysis confirmed minimal deformability of the refined model at molecular level. In addition, disulfide engineering was investigated to accelerate the stability of the protein. Molecular docking study ensured high binding affinity between construct V3 and HLA cells, as well as with different host receptors. Microbial expression and translational efficacy of the constructs were checked using pET28a(+) vector of E. coli strain K12. However, the in vivo and in vitro validation of suggested vaccine molecule might be ensured with wet lab trials using model animals for the implementation of the presented data.
Keywords: COVID-19; Chimeric vaccine; Evolutionary relationship; Molecular docking; Normal mode analysis; Restriction cloning; SARS-CoV-2.
. 2020 Aug 31;104517.
doi: 10.1016/j.meegid.2020.104517. Online ahead of print.
Genome based evolutionary lineage of SARS-CoV-2 towards the development of novel chimeric vaccine
Mst Rubaiat Nazneen Akhand[SUP] 1 [/SUP], Kazi Faizul Azim[SUP] 2 [/SUP], Syeda Farjana Hoque[SUP] 3 [/SUP], Mahmuda Akther Moli[SUP] 3 [/SUP], Bijit Das Joy[SUP] 1 [/SUP], Hafsa Akter[SUP] 4 [/SUP], Ibrahim Khalil Afif[SUP] 5 [/SUP], Nadim Ahmed[SUP] 4 [/SUP], Mahmudul Hasan[SUP] 6 [/SUP]
Affiliations
- PMID: 32882432
- DOI: 10.1016/j.meegid.2020.104517
Abstract
The present study aimed to predict a novel chimeric vaccine by simultaneously targeting four major structural proteins via the establishment of ancestral relationship among different strains of coronaviruses. Conserved regions from the homologous protein sets of spike glycoprotein, membrane protein, envelope protein and nucleocapsid protein were identified through multiple sequence alignment. The phylogeny analyses of whole genome stated that four proteins reflected the close ancestral relation of SARS-CoV-2 to SARS-COV-1 and bat coronavirus. Numerous immunogenic epitopes (both T cell and B cell) were generated from the common fragments which were further ranked on the basis of antigenicity, transmembrane topology, conservancy level, toxicity and allergenicity pattern and population coverage analysis. Top putative epitopes were combined with appropriate adjuvants and linkers to construct a novel multiepitope subunit vaccine against COVID-19. The designed constructs were characterized based on physicochemical properties, allergenicity, antigenicity and solubility which revealed the superiority of construct V3 in terms safety and efficacy. Essential molecular dynamics and Normal Mode analysis confirmed minimal deformability of the refined model at molecular level. In addition, disulfide engineering was investigated to accelerate the stability of the protein. Molecular docking study ensured high binding affinity between construct V3 and HLA cells, as well as with different host receptors. Microbial expression and translational efficacy of the constructs were checked using pET28a(+) vector of E. coli strain K12. However, the in vivo and in vitro validation of suggested vaccine molecule might be ensured with wet lab trials using model animals for the implementation of the presented data.
Keywords: COVID-19; Chimeric vaccine; Evolutionary relationship; Molecular docking; Normal mode analysis; Restriction cloning; SARS-CoV-2.